SMS Lifesciences India Limited

NSE SMSLIFE.NS

SMS Lifesciences India Limited Price to Sales Ratio (P/S) on February 06, 2025: 1.19

SMS Lifesciences India Limited Price to Sales Ratio (P/S) is 1.19 on February 06, 2025, a 121.73% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

SMS Lifesciences India Limited 52-week high Price to Sales Ratio (P/S) is 1.72 on September 09, 2024, which is 43.80% above the current Price to Sales Ratio (P/S).
SMS Lifesciences India Limited 52-week low Price to Sales Ratio (P/S) is 0.53 on February 15, 2024, which is -55.88% below the current Price to Sales Ratio (P/S).
SMS Lifesciences India Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 1.00.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NSE: SMSLIFE.NS

SMS Lifesciences India Limited

CEO	Mr. Talluri Veera Venkata Satyanarayana Murthy
IPO Date	Aug. 18, 2017
Location	India
Headquarters	Plot No. 19-III
Employees	574
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Perfumes & Fragrances Personal Care Plastics

Description

SMS Lifesciences India Limited manufactures, buys, imports, and sells active pharmaceutical ingredients (API) and its intermediates, organic and inorganic chemicals, and pharmaceuticals in India. The company offers APIs in various therapeutic areas, such as antiulcer, antifungal, and erectile dysfunction. It also provides consultancy services. The company exports its products. The company was founded in 1990 and is based in Hyderabad, India.

Key trends

Past 5 years